121 related articles for article (PubMed ID: 20020817)
1. Liposomes modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
J Drug Target; 2010 Jun; 18(5):373-80. PubMed ID: 20020817
[TBL] [Abstract][Full Text] [Related]
2. Polymeric nanospheres modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
Drug Deliv; 2010; 17(7):541-51. PubMed ID: 20560774
[TBL] [Abstract][Full Text] [Related]
3. Liposomes modified with cyclic RGD peptide for tumor targeting.
Dubey PK; Mishra V; Jain S; Mahor S; Vyas SP
J Drug Target; 2004 Jun; 12(5):257-64. PubMed ID: 15512776
[TBL] [Abstract][Full Text] [Related]
4. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin.
Sarfati G; Dvir T; Elkabets M; Apte RN; Cohen S
Biomaterials; 2011 Jan; 32(1):152-61. PubMed ID: 20889205
[TBL] [Abstract][Full Text] [Related]
5. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
Lopez-Barcons LA; Polo D; Reig F; Fabra A
J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
[TBL] [Abstract][Full Text] [Related]
6. RGD modified albumin nanospheres for tumour vasculature targeting.
Dubey PK; Singodia D; Verma RK; Vyas SP
J Pharm Pharmacol; 2011 Jan; 63(1):33-40. PubMed ID: 21155813
[TBL] [Abstract][Full Text] [Related]
7. Antiidiotypic antibodies carrying the "internal image" of peptide YIGSR inhibit spontaneous metastasis of Lewis lung carcinoma in mice.
Koliakos KK; Sapountzi Z; Papageorgiou A; Trachana V; Kotsinou S; Koliakos G
In Vivo; 2002; 16(6):511-8. PubMed ID: 12494895
[TBL] [Abstract][Full Text] [Related]
8. Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life.
Mu Y; Kamada H; Kodaira H; Sato K; Tsutsumi Y; Maeda M; Kawasaki K; Nomizu M; Yamada Y; Mayumi T
Biochem Biophys Res Commun; 1999 Nov; 264(3):763-7. PubMed ID: 10544005
[TBL] [Abstract][Full Text] [Related]
9. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells.
Gupta Y; Jain A; Jain P; Jain SK
J Drug Target; 2007 Apr; 15(3):231-40. PubMed ID: 17454361
[TBL] [Abstract][Full Text] [Related]
10. Synthetic cell-adhesive laminin peptide YIGSR conjugated with polyethylene glycol has improved antimetastatic activity due to a longer half-life in blood.
Kaneda Y; Yamamoto S; Kihira T; Tsutsumi Y; Nakagawa S; Miyake M; Kawasaki K; Mayumi T
Invasion Metastasis; 1995; 15(3-4):156-62. PubMed ID: 8621271
[TBL] [Abstract][Full Text] [Related]
11. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D
Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465
[TBL] [Abstract][Full Text] [Related]
13. Amino acids and peptides. XXXIII. A bifunctional poly(ethylene glycol) hybrid of laminin-related peptides.
Maeda M; Kawasaki K; Mu Y; Kamada H; Tsutsumi Y; Smith TJ; Mayumi T
Biochem Biophys Res Commun; 1998 Jul; 248(3):485-9. PubMed ID: 9703952
[TBL] [Abstract][Full Text] [Related]
14. New analogues of laminin active fragment YIGSR: synthesis and biological activity in vitro and in vivo.
Witkowska E; Oriowska A; Izdebski J; Salwa J; Wietrzyk J; Opolski A
J Pept Sci; 2004 May; 10(5):285-90. PubMed ID: 15160840
[TBL] [Abstract][Full Text] [Related]
15. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
[TBL] [Abstract][Full Text] [Related]
16. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
[TBL] [Abstract][Full Text] [Related]
17. Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis.
Yamamura K; Kibbey MC; Jun SH; Kleinman HK
Semin Cancer Biol; 1993 Aug; 4(4):259-65. PubMed ID: 8400148
[TBL] [Abstract][Full Text] [Related]
18. Antineovascular therapy with angiogenic vessel-targeted polyethyleneglycol-shielded liposomal DPP-CNDAC.
Asai T; Miyazawa S; Maeda N; Hatanaka K; Katanasaka Y; Shimizu K; Shuto S; Oku N
Cancer Sci; 2008 May; 99(5):1029-33. PubMed ID: 18294280
[TBL] [Abstract][Full Text] [Related]
19. Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes.
Katanasaka Y; Ida T; Asai T; Maeda N; Oku N
Int J Pharm; 2008 Aug; 360(1-2):219-24. PubMed ID: 18565703
[TBL] [Abstract][Full Text] [Related]
20. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
